These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22446621)

  • 21. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
    Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
    Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
    Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic analysis of 88 patients with ovarian clear cell carcinoma].
    Ma SK; Zhang HT; Wu LY; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):784-8. PubMed ID: 18396695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
    Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
    J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
    Rubin SC; Wong GY; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
    Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sertoli-Leydig cell tumor of the ovary.
    Chen FY; Sheu BC; Lin MC; Chow SN; Lin HH
    J Formos Med Assoc; 2004 May; 103(5):388-91. PubMed ID: 15216408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysgerminoma: the role of conservative surgery.
    Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
    Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sertoli-Leydig cell tumor of the ovary].
    Youssef A; Ben Ghezala M; Oueslati A; Agrebi W; Oueslati H
    Tunis Med; 2006 Mar; 84(3):209-11. PubMed ID: 16755966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.